| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.13T | 3.53T | 2.87T | 2.81T | 2.66T | 2.51T |
| Gross Profit | 1.14T | 1.13T | 1.20T | 1.17T | 1.04T | 940.79B |
| EBITDA | 1.21T | 1.37T | 944.66B | 916.36B | 813.04B | 743.78B |
| Net Income | 469.53B | 475.04B | 351.63B | 346.13B | 290.34B | 317.38B |
Balance Sheet | ||||||
| Total Assets | 18.13T | 18.08T | 16.87T | 16.32T | 15.29T | 14.27T |
| Cash, Cash Equivalents and Short-Term Investments | 1.42T | 1.46T | 3.81T | 1.05T | 1.26T | 971.10B |
| Total Debt | 6.71T | 6.57T | 6.28T | 6.46T | 6.01T | 5.16T |
| Total Liabilities | 13.40T | 13.44T | 12.69T | 12.30T | 11.67T | 10.90T |
| Stockholders Equity | 4.58T | 4.50T | 4.09T | 3.94T | 3.54T | 3.26T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.38T | 1.20T | 1.17T | 777.66B | 990.65B |
| Operating Cash Flow | 0.00 | 1.46T | 1.27T | 1.25T | 881.23B | 1.03T |
| Investing Cash Flow | 0.00 | -1.18T | -1.31T | -1.36T | -1.14T | -784.99B |
| Financing Cash Flow | 0.00 | -170.22B | 146.27B | -100.99B | 480.70B | -330.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $9.86B | 19.31 | 15.91% | 0.99% | 14.39% | 27.91% | |
71 Outperform | $37.88B | 11.19 | 10.13% | 2.72% | 16.88% | 32.48% | |
70 Outperform | $23.90B | 7.23 | 21.41% | 1.34% | -3.18% | 32.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $6.18B | 6.91 | 23.62% | 6.07% | 7.80% | 42.28% | |
62 Neutral | $2.64B | 10.62 | 47.95% | 10.18% | -2.34% | -49.33% | |
61 Neutral | $12.91B | 9.56 | 9.19% | 2.58% | -0.72% | 198.95% |